Latest News

Following the conclusion of the inquest into the death of Alexandra Briess, the coroner has issued a prevention of future deaths report.  Prevention of future deaths reports are written when the coroner…

To coincide with World Immunology Day 2023, the British Society for Immunology is holding an event for the public called “Allergy : A misguided immune response in our lungs, skin or gut”.

Allergy Therapeutics, a biotechnology company specialising in the treatment and diagnosis of allergic disorders, has announced the first application of VLP Peanut in peanut allergic patients has commenced.

Imperial College London is offering up to five scholarships for UK or international applicants for the next academic year 2023-2024.

A new analysis that looked at the optimal timing of introducing peanut products to babies to prevent peanut allergy suggests that a 77% reduction in peanut allergy could be achieved if peanut was introduced to all babies at four to six months of age. 

Following a scientific review of the safety of pholcodine, the Medicines and Healthcare products Regulatory Agency (MHRA), with advice from the independent Commission on Human Medicines, has recommended that all pholcodine-containing cough and cold medicines should be withdrawn as a precautionary measure. 

Anaphylaxis UK is urging healthcare professionals to make sure that medication prescribed to their patients does not contain ingredients that they are allergic too.  

A review of recent data regarding frequency of allergic reactions has shown similar rates of anaphylaxis to COVID vaccines as to other vaccines.  

The Patient Information Forum (PIF) has today (28 February) launched a new PIF TICK toolkit to help healthcare professionals provide trusted information to their patients.